Genetic Tech. (GENE) Enters Settlement, License with Promega Corp.

March 24, 2014 12:49 PM EDT
Get Alerts GENE Hot Sheet
Trade GENE Now!
Join SI Premium – FREE
Genetic Technologies Limited (Nasdaq: GENE) announced that in compliance with the ASX Continuous Disclosure Rules, the company is pleased to report the execution of a Settlement, Covenant and License Agreement with Promega Corporation, which has a principal place of business in Madison, Wisconsin, USA.

Under this Agreement, GTG grants broad rights to Promega in relation to GTG's Intron Sequence Analysis and Genomic Mapping patents. The precise commercial terms of this Agreement are covered by formal confidentiality provisions and cannot be disclosed.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation

Add Your Comment